JESSICA PACUCH: Open Payments
NPI 1558824698 · RAPHINE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 44 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $238 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 27 | $327 |
| Collegium Pharmaceutical, Inc. | 5 | $99 |
| Neuronetics, Inc. | 2 | $71 |
| ABBVIE INC. | 3 | $51 |
| Corium, LLC | 3 | $44 |
| Lundbeck LLC | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: Qelbree, Jornay PM, NEUROSTAR TMS THERAPY SYSTEM, ABILIFY MAINTENA, VRAYLAR, Azstarys, CAPLYTA.
Industry payments across VA — which companies pay providers there.
